Methotrexate, Doxorubicin, and Cisplatin (MAP) Plus Maintenance Pegylated Interferon Alfa-2b Versus MAP Alone in Patients With Resectable High-Grade Osteosarcoma and Good Histologic Response to…

Overview of attention for article published in Journal of Clinical Oncology, June 2015

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (86th percentile)
Good Attention Score compared to outputs of the same age and source (68th percentile)

Mentioned by

twitter: 10 X users
patent: 2 patents

facebook: 1 Facebook page

Citations

dimensions_citation: 335 Dimensions

Readers on

mendeley: 253 Mendeley
citeulike: 2 CiteULike

Summary X Patents Facebook Dimensions citations

So far, Altmetric has seen 1 public wall post.

LESS - Arbeitsgruppe Spätfolgen, Late Effects Surveillance System, 09 Jul 2015

Methotrexate, Doxorubicin, and Cisplatin (MAP) Plus Maintenance Pegylated Interferon Alfa-2b Versus MAP Alone in Patients With…

This page shows the most recent Facebook posts that mention this research output.

Click here to find out how to access more activity.